Placental Vascular Pathologies Clinical Trial
Official title:
Prospective Multicentric Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women With a Risk of Thromboembolism and/or a Risk of Placental Vascular Complication, Strategy Determined With a Risk Score.
The venous thromboembolism is one of the first causes of maternal mortality. Until 2003, only
a few recommendations were available on the optimal use of antithrombotic therapy as a
preventive measure against thromboembolism in pregnant women. In this study, we propose :
1. To gather the experts who took part in the French consensus conference and the local
experts to create a score in accordance with the national and international consensus
and to give some precise therapeutic strategies.
2. To evaluate the discriminant, feasible and useful character of this new score by a
prospective multicentric study including 2000 pregnant women with a risk of
thromboembolism or placental vascular pathology who will benefit from therapeutic
strategies defined by the new score.
Purpose : To create a score inspired by our first experience i.e. simple, standardized and quickly usable in day-to-day practice to individualize antithrombotics prescription to women at risk. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00695942 -
Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease
|
N/A |